update to protocol cleared by the FDA and trial costs significantly reduced! The only negative is we have to wait until October to start, that's only a 4-6 week delay as far as I can see, a millisecond in the biopharma space.
Ann: ISLA-101 Phase 2a/b clinical trial progresses, page-2
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $28.06M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 17.0¢ | $54.79K | 306.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14999 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 122229 | 2 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| ILA (ASX) Chart |